PMID- 10508618 OWN - NLM STAT- MEDLINE DCOM- 20000214 LR - 20191210 IS - 0960-9822 (Print) IS - 0960-9822 (Linking) VI - 9 IP - 18 DP - 1999 Sep 23 TI - Recruitment of Dok-R to the EGF receptor through its PTB domain is required for attenuation of Erk MAP kinase activation. PG - 1057-60 AB - Dok (for downstream of tyrosine kinases) proteins are a newly identified family of docking molecules that are characterized by the presence of an amino-terminal pleckstrin homology (PH) domain, a central putative phosphotyrosine-binding (PTB) domain and numerous potential sites of tyrosine phosphorylation [1] [2] [3] [4] [5] [6]. Here, we explore the potential role of the Dok family member Dok-R (also known as p56(Dok2) or FRIP) in signaling pathways mediated by the epidermal growth factor (EGF) receptor. An intact PTB domain in Dok-R was critical for its association with two PTB-binding consensus sites on the EGF receptor and the PH domain further contributed to stable in vivo binding and tyrosine phosphorylation of Dok-R. Multiple sites on Dok-R were tyrosine-phosphorylated following EGF stimulation; phosphorylated Tyr276 and Tyr304 are proposed to dock the tandem Src homology 2 (SH2) domains of the p21(Ras) GTPase-activating protein rasGAP and Tyr351 mediates an association with the SH2 domain of the adapter protein Nck. Interestingly, we have found that Dok-R could attenuate EGF-stimulated mitogen-activated protein (MAP) kinase activation independently of its association with rasGAP. Together, these results suggest that Dok-R has an important role downstream of growth factor receptors as a potential negative regulator of signal transduction. FAU - Jones, N AU - Jones N AD - Division of Cancer Biology Research Sunnybrook and Women's College Health Sciences Centre Department of Medical Biophysics University of Toronto Toronto, Ontario, Canada. FAU - Dumont, D J AU - Dumont DJ LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - Curr Biol JT - Current biology : CB JID - 9107782 RN - 0 (Adaptor Proteins, Signal Transducing) RN - 0 (Adaptor Proteins, Vesicular Transport) RN - 0 (Carrier Proteins) RN - 0 (DOK2 protein, human) RN - 0 (GRB2 Adaptor Protein) RN - 0 (Nck protein) RN - 0 (Oncogene Proteins) RN - 0 (Phosphoproteins) RN - 0 (Proteins) RN - 0 (Recombinant Fusion Proteins) RN - 0 (Shc Signaling Adaptor Proteins) RN - EC 2.7.10.1 (ErbB Receptors) SB - IM MH - *Adaptor Proteins, Signal Transducing MH - *Adaptor Proteins, Vesicular Transport MH - Amino Acid Sequence MH - Animals MH - COS Cells MH - Carrier Proteins/chemistry/*metabolism MH - Chlorocebus aethiops MH - Enzyme Activation MH - ErbB Receptors/*metabolism MH - GRB2 Adaptor Protein MH - MAP Kinase Signaling System/*physiology MH - Molecular Sequence Data MH - Oncogene Proteins/metabolism MH - Phosphoproteins/chemistry/*metabolism MH - Phosphorylation MH - Protein Binding MH - *Protein Processing, Post-Translational MH - Protein Structure, Tertiary MH - Proteins/metabolism MH - Recombinant Fusion Proteins/metabolism MH - Shc Signaling Adaptor Proteins MH - Transfection MH - src Homology Domains EDAT- 1999/10/06 09:00 MHDA- 2000/02/19 09:00 CRDT- 1999/10/06 09:00 PHST- 1999/10/06 09:00 [pubmed] PHST- 2000/02/19 09:00 [medline] PHST- 1999/10/06 09:00 [entrez] AID - S0960-9822(99)80458-8 [pii] AID - 10.1016/s0960-9822(99)80458-8 [doi] PST - ppublish SO - Curr Biol. 1999 Sep 23;9(18):1057-60. doi: 10.1016/s0960-9822(99)80458-8.